Skip to content

Evaluate The Efficacy Of Ashtamangala Ghrita On Medha In School Going Children W.S.R To Cognitive Skills.

Randomized Controll Clinical Study to Evaluate The Efficacy Of Ashtamangala Ghrita on Medha In School Going Children W.S.R To Cognitive Skills. - RCAC

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024485
Enrollment
30
Registered
2020-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F70- Mild intellectual disabilities

Interventions

Intervention1: Ashtamangala ghrita: Ashtamangala ghrita will be given orally along with breakfast for 30 days Dose- 07 years to 8 years- 07 Masha( 7gm) 8.1 years to 09years- 08 Masha (8 gm)

Sponsors

Dr Krishnapriya T S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CHILDREN IN WHOM PARENTS ARE WILLING TO SIGN WRITTEN CONSENT FORM

Exclusion criteria

Exclusion criteria: KNOWN CASE OF ADHD,ASD,MENTAL RETARDATION, DEVELOPMENTAL DISORDERS, PSYCHIATRIC DISORDERS,CHRONIC SYSTEMIC ILLNESS, GENETIC SYNDROMES

Design outcomes

Primary

MeasureTime frame
By Consuming Ashtamangala Ghrita, It Will Improve Medha(Cognitive Skill),And assessment will be done using Ravens Educational CPM/CVS INDIA scaleTimepoint: 1st follow up - 30 Days after completion of treatment 2nd follow up- 60 Days after completion of treatment

Secondary

MeasureTime frame
To study the normal process of cognitive skills, And assessment will be using Ravens Educational CPM/CVS (INDIA) Scale.Timepoint: 1st follow up- 30 Days after completion of treatment 2nd follow up- 60 Days after completion of treatment

Countries

India

Contacts

Public ContactDr Krishnapriya T S

Sri Sri College Of Ayurvedic Science And Research

sudheerbrao@yahoo.co.in6282545345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026